AFJK · Aimei Health Technology Co., Ltd

Aimei Health Technology Co., Ltd, a blank check company listed on Nasdaq under ticker AFJK, disclosed receiving a deficiency notice from Nasdaq's Listing Qualifications Department on April 17, 2026. The notice stems from the company's failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was due on March 31, 2026. The company had previously filed a Form 12b-25 notification of late filing on April 1, 2026, indicating an extension request, but has yet to submit the full report. This violation of Nasdaq Listing Rule 5250(c)(1), which mandates timely filing of periodic reports with the SEC, puts the company at risk of delisting if compliance is not regained. Currently, there is no suspension of trading or delisting proceedings initiated. The company has a 60-calendar-day window from the notice date—until mid-June 2026—to either file the overdue 10-K or present a compliance plan to Nasdaq. Acceptance of the plan could extend the grace period up to 180 days from the original due date, potentially into late September 2026, with appeal rights available if rejected. Management states it is diligently working on the report and anticipates regaining compliance, though no specific filing timeline is provided. Investors should monitor for the 10-K filing, as prolonged delays could trigger delisting, impacting liquidity and market access for AFJK shares. The attached Exhibit 99.1 press release reiterates these details and complies with Nasdaq's prompt disclosure requirements under Rule 5810(b).